Advertise with us
Clinical Group

Annals of Alzheimer's and Dementia Care


Recent articles to be released shortly in Volume-2

Citicoline in Vascular Cognitive Impairment: Some Latest Evidences

Published On: July 17, 2017 | Pages: 018 - 019

Author(s): Pietro Gareri* and Alberto Castagna
CDP-choline (cytidine-5′-diphosphate choline), also called citicoline, is one of the most frequently pre scribed drugs for cognitive impairment in several European countries and worldwide. ...
Abstract View Full Article View

Case Report of Clinically Probable Sporadic Creutzfeldt - Jakob Disease from A Tertiary Care Hospital in South India

Published On: April 03, 2017 | Pages: 013 - 017

Author(s): Shaik Afsar Pasha, Ankamma Rao, Phani Bhushan, Bhaskara Rao B and Prasunpriya Nayak*
We are reporting an otherwise healthy lady of forty eight years suffering from rapidly progressive dementia, behavioural disturbances, myoclonus, ataxia and extrapyramidal features of eight months duration with characteristic abnormalities on brain imaging, electroencephalography with positive cerebrospinal fluid 14-3-3 protein, satisfying the revised World Health org ...
Abstract View Full Article View

Can Exposure to Volatile Anesthetics Be a Tipping Point for AD Susceptible Populations?

Published On: February 22, 2017 | Pages: 007 - 012

Author(s): Ingrid R Niesman*
The relationship between surgery induced Postoperative Cognitive Dysfunction (POCD) and the development of Alzheimer’s disease (AD) later has been a debatable question. Volatile anesthetics represent a potential environmental factor that can change the CNS both acutely and long-term. ...
Abstract View Full Article View

Amisulpride in Refractory Behavioral and Psychological Symptoms of Dementia

Published On: January 03, 2017 | Pages: 001 - 006

Author(s): Vikas Dhikav*, Dolly Prajapati, Wasifa Muzaffar, Nidhi Agarwal, Sekh Raisuddin, Kuljeet Singh Anand
Background: Amisulpiride is an atypical antipsychotic used extensively in Schizophrenia and related disorders. The current study explored the safety and tolerability of amisulpride in refractory patients with behavioral and psychological symptoms of dementia (BPSD), especially in agitation and/or aggression. ...
Abstract View Full Article View